precoopera: giredestrant versus anastrozole in er /her2- early breast cancer
Published 1 month ago • 102 plays • Length 1:44Download video MP4
Download video MP3
Similar videos
-
6:23
alternate: fulvestrant and/or anastrozole in er her2- postmenopausal breast cancer
-
1:05
cambria 1: camizestrant er /her2- early breast cancer
-
0:51
ember-2: preoperative imlunestrant for er /her2- early stage breast cancer
-
4:45
giredestrant plus palbociclib vs anastrozole plus palbociclib for post-menopausal, her2-negative...
-
2:59
talent: neoadjuvant t-dxd with or without anastrozole for her2-low, hr early stage breast cancer
-
2:46
ameera-3: amcenestrant does not improve pfs in er /her2- breast cancer
-
2:06
unmet needs and cdk4/6 inhibitors in hr /her2- early breast cancer
-
0:55
cambria-1: camizestrant vs standard endocrine therapy in breast cancer
-
1:56
optimizing adjuvant treatment in hr /her2- early breast cancer
-
1:02
results of ember-2: imlunestrant two weeks prior to surgery for er /her2- early stage breast cancer
-
0:30
the role of serds in the treatment landscape of patients with er /her2- breast cancer
-
4:37
predict underestimates survival of patients with her2 early breast cancer
-
0:52
first-line camizestrant for er /her2- advanced breast cancer
-
1:27
emerald: elacestrant vs physicians choice in er /her2- breast cancer
-
1:31
mirador: monitoring mrd using ctdna in hr /her2- early breast cancer
-
3:04
12-year results of anastrozole vs tamoxifen for breast cancer prevention
-
1:17
key trial updates in serds in er /her2- breast cancer from sabcs 2022
-
4:12
optimizing treatment in patients with early-stage her2-positive breast cancer
-
2:30
monarche: abemaciclib and adjuvant endocrine therapy for high-risk hr early breast cancer